skip to Global Navigation Bar
skip to main content
HOME
CONTACT US
SITEMAP
KOREAN
Global Business
Introduction
Strategy
Manufacturing
Contact Us
R&D
Introduction
Global R&D Centers
R&D Organization
Pipeline
CDMO
Introduction
Manufacturing Sites
Business Model
Service Range
Products
Global Brand
Products Search
In-License
Introduction
Strategy
No.1 Position
Core-Competency
Licensed Products
Partnership
Investors
Management information
Financial information
Stock condition
IR information
About Us
Company Profile
CEO Message
Recruitment
Press Release
Company Profile
CEO Message
Recruitment
Press Release
News
PR Video
Home > About Us > Press Release >
News
뉴스
No
Subject
Data
175
Daewoong signs 3-party MOU with CGBio-VANCIVE
2014-06-17
174
‘Impectamin’ changes the paradigm in the Vitamin B market
2014-06-13
173
NABOTA received approval from Thailand
2014-06-09
172
Daewoong Pharmaceutical inks contracts to export Caretropin, a liquid growth hormone product, and syringes to three countries
2014-05-26
171
Pharmaceutical safety management officials of Southeast Asian countries visited Daewoong Pharmaceutical
2014-04-28
170
Daewoong Pharmaceutical set up Compliance Team to spur business transparency
2014-04-22
169
Daewoong Pharmaceutical joins forces with Daiichi Sankyo Korea for co-promotion of ‘OLOSTAR’
2014-04-18
168
Daewoong Pharmaceutical announced its vision for ‘NABOTA’ sweeping the global botulinum toxin market
2014-04-16
167
Imatinib, a drug for the treatment of chronic myelogenous leukemia, makes full-scale entry into Iranian market
2014-04-10
166
Daewoong Pharmaceutical and Daewoong Bio made their presence felt at CPhl Japan and CPhI Russia
2014-04-09
1
/
2
/
3
/
4
/
5
/
6
/
7
/
8
/
9
/
10
/
News Search
subject
content
Home > About Us > Press Release > News
Home > About Us > Press Release > News